chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No adverse effect; M-M-R II underwent a temperature excursion prior to being administered; This spontaneous report was received from an other healthcare professional referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant medications and drug reactions/allergies were not reported.  On 09-JUL-2019 at evening, the vaccine underwent temperature excursion at a temperature of 12.4ºC for 19 hours and it finished on the next day (10-JUL-2019) at morning. On the same day, the patient was vaccinated with an improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) lot # R014689 and expiration date: 23-MAY-2020, subcutaneously for prophylaxis (strength, dose, unit, anatomical location, lot # and expiration date were not reported) (product storage error). No adverse effects were reported. No previous temperature excursions were reported. The call was due to digital data logger. The outcome of product storage error was unknown. No product quality complaint (PQC) was involved.
This spontaneous report was received from a pharmacist refers to a patient (age and gender unknown). On 19-FEB-2013, the patient was vaccinated with ZOSTAVAX (lot # 672478/1603AA; expiration date on 13-JAN-2013) 0.65 ml, subcutaneous route as prophylaxis. No adverse event reported. Additional information has been requested.
Disequilibrium; Felt like she was going to fall and vertigo; Both shoulders became sore; Arm of the vaccine site became numb; Arm of the vaccine site with pins and needles; Intense dizziness; This is a spontaneous report received from a contactable consumer. The reporter is the patient.  A 19-year-old female patient (not pregnant) received BNT162B2 (BNT162B2), administered in arm left, administration date 24Jan2022 09:15 (Batch/Lot number: unknown) at the age of 19 years as dose 3 (booster), single for COVID-19 immunization. Relevant medical history included: "Birth control" (unspecified if ongoing); "COVID-19" (unspecified if ongoing), notes: Diagnosed prior to vaccination. Concomitant medications included: DROSPIRENONE; ETHINYL ESTRADIOL. Vaccination history included: BNT162B2 (DOSE 1; 04:00 PM; left arm), administration date: 09Apr2021, when the patient was 18 years old, for COVID-19 immunization; BNT162B2 (DOSE 2; Lot Number: EW0179; 05:30 PM; left arm), administration date: 11May2021, when the patient was 18 years old, for COVID-19 immunization. The following information was reported: DIZZINESS (non-serious) with onset 24Jan2022 09:45, outcome "recovering", described as "Intense dizziness"; BALANCE DISORDER (non-serious) with onset 24Jan2022 18:00, outcome "recovering", described as "Disequilibrium"; VERTIGO (non-serious) with onset 24Jan2022 18:00, outcome "recovering", described as "Felt like she was going to fall and vertigo"; ARTHRALGIA (non-serious) with onset 24Jan2022 18:00, outcome "recovering", described as "Both shoulders became sore"; HYPOAESTHESIA (non-serious) with onset 24Jan2022 18:00, outcome "recovering", described as "Arm of the vaccine site became numb"; PARAESTHESIA (non-serious) with onset 24Jan2022 18:00, outcome "recovering", described as "Arm of the vaccine site with pins and needles". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of dizziness, balance disorder, vertigo, arthralgia, hypoaesthesia, paraesthesia.  Additional Information: The patient had no known allergies and with family history of blood clotting. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient had intense dizziness for 30 minutes period after vaccine. At 18:00 (also reported as 9 hours later), more intense dizziness began again paired with disequilibrium where the patient felt like she was going to fall, and vertigo. Both shoulders became sore, and the patient's arm of the vaccine site became numb and with pins and needles. The events were considered non-serious by the patient. Since the vaccination, the patient has been tested for COVID-19 (PCR nasal swab) that was negative on 22Jan2022.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a registered nurse refers to an unknown number of patients. No patients' demographics were provided. It was reported that on 01-JUL-2014 an unknown number of patients were administered (Oka/Merck) VARIVAX after it reached a temperature of 11F for 45 minutes. The vaccines were administered subcutaneously, sites of administrations, doses, lot# and expiration dates not reported. The temperature excursion was supported. No adverse effects were reported. Additional information has been requested.
Myocarditis,with abnormal EKG-they said this is just inflammation; Abnormal EKG; This is a spontaneous report from a contactable consumer (patient). This is report 1 of 3. A female patient of an unspecified age was reporting for herself that she was received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EW0176, NDC/Expiry: Not provided), via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient was received first dose of BNT162B2 on an unspecified date for Covid-19 immunization and no reaction on previous exposure to vaccine. On an unspecified date, the patient experienced myocarditis, abnormal Electrocardiogram (EKG) and inflammation. Additional context reported as the patient was consumer also patient for this report who got second dose of Pfizer Covid Vaccine and had adverse event of Myocarditis with onset 7 days after second dose-ended up in urgent care with abnormal EKG-they said this is just inflammation and it took 4 weeks to go away for her. Patient had first dose of Pfizer Covid Vaccine with different Lot number and had no problem after that first dose. The patient knows they are only talking about that with 19-year-old. They are all fine, but it might be an issue of bad batches of Lot numbers of Pfizer Covid Vaccine. They all recovered. The patient underwent lab tests and procedures which included EKG: abnormal on an unspecified date. Therapeutic measures were taken as a result of myocarditis, abnormal EKG. Outcome of the events was recovered.  Follow up attempts are needed. Additional information has been requested.
I got chilly; mild headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (I got chilly) and HEADACHE (mild headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039F21A, 024821A and 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Nov-2021, the patient experienced CHILLS (I got chilly) and HEADACHE (mild headache). At the time of the report, CHILLS (I got chilly) and HEADACHE (mild headache) had resolved.            No concomitant medication were reported.   No treatment drug were reported.   This case was linked to MOD-2022-542607, MOD-2022-542609, MOD-2022-542615 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 18-Apr-2022: Follow up document contain non significant information.
Swelling of Left arm & shoulder and very hot to touch.  Areas itching for 48 hours - elevated temp (101F) for 72 hours.  Child sleeping more than 12 hours X 48 hours but eating well & playing.  Mom using comfort measures.  If child does not recover by 24-48 hours, mother will take to private physician.
Hives, itching, and burning that occurs everyday all throughout the day since 2/7/22.
Small bump initially as expected. Within 10 hours bump had dissipated and formed a Quarter-sized inflamed red spot that was warm to the touch and surrounded the injection site. Patient was also running a mild fever at 99.8F.  When patient woke up the following day the inflamed area grew to around 2.5 inches in diameter was still warm to the touch.
Patient experienced headaches - similar to sinus headaches daily for 1 month, starting day after vaccination. then it progressed to headaches every other day for ~1 month and then headaches every week and every other week. she is still experiencing headaches on days she is not sleeping well.  Treatment: resolved with tylenol however headaches will reoccur. Patient  is staying well hydrated as it seems to prevent headaches
Temp 101 degrees F, stiff arm, redness and swelling, unable to abduct arm past 90 degrees for 2 days where vaccine given.
On 12/11 patient's blood was drawn for lab work.  About 3 days after vaccine, outside of shoulder at injection site, area was slightly swollen including tendons as it limited movement. Patient took aspirin but it did not help much. Today the tension is not as bad but it is pinching a nerve with certain movements; that is, feels  tension when extending arm to side until it gets shoulder height or feels a cramp when puts arm behind back.    On 1/27/20 went to doctor's office and staff directed him to the vaccine provider.  Then the pharmacy directed patient to VAERS but neither provided advice. Patient has doctor appointment scheduled for 2/5.   Arm is improving, recovery at 60%.
This case was reported by a consumer and described the occurrence of infection in a 81-year-old female patient who received SHINGRIX. On 20th April 2018, the patient received the 1st dose of SHINGRIX. In April 2018, less than a week after receiving SHINGRIX, the patient experienced infection, swelling, rash and pain in arm. The patient was treated with nutritional supplement (Probiotics). On an unknown date, the outcome of the infection, swelling, rash and pain in arm were unknown. It was unknown if the reporter considered the infection, swelling, rash and pain in arm to be related to SHINGRIX. Additional information were provided as follows: The reporter stated that, she was provided with information about possible rash but no photo of how the rash would looked like. As anticipated, the patient had pain in arm and swelling along with a developing rash. The reporter stated that her arm was began to swell far more and over the next tow day the rash grew much larger. On 22nd April 2018, though still uncertain if the swelling and rash were in the normal range, she decided to go to the emergency room where it was determined that she had an infection. The course of antibiotics started along with a course of probiotic. The reporter call the pharmacy where the vaccine was given and asked if they had any policy to cover costs expenses as a result an infection due to their shot. It was suggested they the reporter should contact GlaxoSmithKline directly. The reporter stated that the cost of antibiotics was not great and the probiotics were some she had in the house (though she would have to buy a new box of probiotics), but they also had to spend time and gas traveling to the hospital and next day to the pharmacy. The reporter hoping that GlaxoSmithKline might have a policy that fairly reimbursed a client who wound up with unexpected bills because of an infection that resulted from shot given by pharmacy. This case was linked with US2018GSK076230, reported by the same reporter.
A 35 year old FEMALE who presents to monitoring station after getting Covid 19  vaccine, after a few minutes c/o lightheadedness, no other accompanying symptoms. Discussed with patient current symptoms, only lightheaded, no other accompanying  symptoms. Initially HBP. Provided PO hydration. Patient recovered after a few  minutes. Discharged to her working  area w/o symptoms. Advised to return to ER if any  headache, increased lightheadedness,  chest pain, asthma exacerbation, abdominal  pain, N/V. Employee agreed understanding instructions.
Starting on the 1st  day of the 2nd dose vaccine-elevated heart rate, chills, fever, body aches, nausea, neuropathy (hands, feet, arm and lower legs feels like pins and needles) and loss of appetite.  Participant took Tylenol and Zofran. Fever and body aches resolved after 48 hours.  Tachycardia and chest pains continued for up to 6 weeks. Participant had a follow-up already scheduled on 1/25/2021.  Cardiologist doubled the dose of propranolol.   As of now, cardiovascular symptoms and neuropathy  are not resolved. MRI and stress test have been ordered .
Presented 3/30/2021 to (ENT) for evaluation of bilateral ear pressure and facial numbness. He reports he has had bilateral ear pressure for 5 days, and has had facial numbness bilaterally below and in front of the ears for 2 days. He states he has had a ringing tinnitus and equalization issues in bilateral ears. He has had a similar issue after going on an air plane but his ears typically are able to equalize. He has not had any changes in otorrhea, dizziness, or true vertigo during this time. No prior history of ear infections, surgery, or trauma. He denies any nasal congestion, pressure or hx of allergies. He got his COVID vaccine last Saturday, a few days before symptoms started. Pt is very concerned about symptoms and potentially having stroke symptoms. Pt denies changes in gross/fine motor, vision, speech, or any evident paralysis.   Steroids were given. He hasn't had any significant improvement of his hearing at this time.  4/9/21: "HPI: Pt reports back sooner then expected due to no improvement in hearing loss post 10 days of 60 mg of prednisone. Pt reports post his first dose of prednisone the numbness which was originally in front of both ears worsened to his whole side of his R face as well as continued to be in front of his L ear. Pt thought he was having a stroke and went to ER where blood work, a CT, and multiple others tests were done which per Pt report were normal. Pt did not bring results from the ER just his discharge paperwork. Pt was told to f/u with Neurology but could not get in till June and felt if he returned to ENTAA care sooner, we would have pull in getting Pt into see Neurology sooner. Pt feels the facial numbness and hearing loss are related and if he can fix the numbness his hearing loss will resolve. Pt would like to wean off prednisone since it has not been beneficial and wants to defer dex injections at this time. Pt would like to f/u post his neurology appointment. Pt denies any improvement in hearing, numbness, pressure, or tinnitus."  Patient's physical exam was within normal limits today. Patient's MRI to evaluate facial numbness and asymmetrical hearing loss showed no acute findings, including no evidence of vestibular schwannoma or prior stroke. We discussed the possible dehiscence of the covering of the right superior semicircular canal and how he does not present with the typical pathology we would expect with this finding. Per the radiologist's recommendation for a temporal bone CT, I suggested this for the patient but he ultimately defers at this time. Patient defers Dex injection at this time so I highly recommended he follow up with Neurology as soon as he can. He will return in five months for a comprehensive audiogram.  Follow-Up in five months with audiogram beforehand
Pt was at clinic with mom for immunizations. NKDA. Mom stated that Pt ?passed out? after last vaccines. I advised pt to remain seated and take deep breaths during shots. Pt stated he ate breakfast. Gave Hepatitis A and flu in right deltoid. Pt tolerated well. He stood up and turned chair to do left arm. Gave Menactra then HPV in left deltoid. Several seconds after last vaccine pt turned pale and lost consciousness. Pt remained in chair and coughing and shaking. Pts? mom and I tried to arouse pt. He was unconscious less that one minute. When he awoke he said he was fine. I instructed him to stay seated. He asked for something sweet and we gave him some hard candy. I ask if pt was diabetic or hypoglycemic and mother said no. After several minutes, when pt felt better and his color came back, pt stood up and went to car. Other nurse provided standby assistance to car. Advised pt and mom to notify providers about fainting before any future vaccines.
Information has been received on 15-FEB-2019 regarding a case in litigation from a lawyer concerning an approximately 68 year old female patient of unknown age. There was no information provided regarding the patient's concurrent conditions, medical history or concomitant medications. The patient was prescribed the ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. In 2008, the patient was administered the ZOSTAVAX (lot number, expiration, dose and route unknown) by a healthcare provider at a community health care. In 2015, the patient was treated by a healthcare provider at a medical center for the following injuries resulting from the patient's ZOSTAVAX use: shingles. The patient claims damages as a result of injury to self and economic losses. The outcome of the event is unknown. The causality of the event is related. Additional information has been requested.
The day of my first dose (January 23) I felt a bit numb in the head but thought it would be okay. That did clear up.  I was however very weak after the first dose but improved.  By February 7, I had been feeling pulsations in my head and I checked that I had a BP over 200/100 and went to the ER. I was given a low dose amplodipine however my primary care doctor checked my urine and found very high proteinuria. Eventually I followed up with a nephrologist after being given an urgent referral and was diagnosed with membrane nephropathy due to high PLA2R levels. My proteinuria was 13 g/day (severe) and I had very high cholesterol and low serum albumin (2.5 mg/dl).  He mentioned that the vaccine has unmasked it in several people.  I have received treatment of 10 mg Lisinopril, 20 mg Simvastatin, 81 mg aspirin and have received my first infusion of 1 g Rituximab and will follow with a second infusion 2 weeks later.
This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ASTHMA (Asthma but it is intensified today), INJECTION SITE PRURITUS (itchy), INJECTION SITE SWELLING (arm is swollen) and VACCINATION SITE PAIN (arm soreness) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The patient's past medical history included Asthma. Concurrent medical conditions included Shellfish allergy. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE PAIN (arm soreness). On 08-Feb-2021, the patient experienced ASTHMA (Asthma but it is intensified today), INJECTION SITE PRURITUS (itchy) and INJECTION SITE SWELLING (arm is swollen). At the time of the report, ASTHMA (Asthma but it is intensified today), INJECTION SITE PRURITUS (itchy), INJECTION SITE SWELLING (arm is swollen) and VACCINATION SITE PAIN (arm soreness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information included patient consulted her doctor and gave her some pills.
I started my period 2.5 weeks early 6 hours after my 2nd dose of covid vaccine.
Single vial of multidose vaccination remains in box of vaccines.  We were unable to determine which patient did not receive the full dose.  No adverse reaction from patient.
Received influenza vaccine in L deltoid (posterior/superior aspect) 10/29/03.  Reports that she had immediate pain with numbness/tingling radiating down her L arm to palmar aspects of all digits. Symptoms waned in about 1 hour, but persisted.  Presents 11/17/03 with one day of increased tenderness/pain at injection site with decreased range of motion L shoulder (abduction & elevation)and L arm/hand numbness & tingling.
Fever; chills; body aches; muscle cramps; headache; vomiting; diarrhea; loss of bladder control; labored breathing; This is a spontaneous report from a contactable consumer (patient). A 45-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, lot number: EW0161, expiration date was not reported), via an unspecified route of administration, administered in left arm on 12Apr2021 14:30 (at the age of 45-years-old) as dose 2, single for covid-19 immunization at pharmacy or drug store. The patient medical history included breast cancer survivor, currently suffering PLC body rash, drug Known allergies: Sulfa drug, body rash. Concomitant medication included valaciclovir hydrochloride (VALTREX), lorazepam, citalopram.  Other medications patient received in two weeks included valtrex, lorazapram, citralopram. The patient historical vaccine included first dose of BNT162B2 (lot number: ER8730, expiration date was not reported), via an unspecified route of administration, administered in left arm on 22Mar2021 02:30 PM (at the age of 45-years-old) as dose 1, single for covid-19 immunization. Patient did not receive other vaccine in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.It was reported that on 13Apr2021 12:30 AM the patient experienced fever, chills, body aches, muscle cramps, headache, vomiting, diarrhea, loss of bladder control, immediate onset of period, labored breathing. No treatment received for adverse events. The outcome of the events was recovering.  Follow-up attempts are completed. No further information is expected.
The doctor's office previously listed was where I was treated for the adverse reaction. The vaccine was administered at (pharmacy) on (withheld) Road, (city withheld). In late August I developed shingles, despite having had the full Shingrex vaccine in 2018 (and the less effective one some years earlier). I have also been diagnosed with shingles twice some decade ago. The marks are still present 5-6 weeks later, but no further outbreaks, pain or itching. I was prescribed an antiviral, and later a steroid for pain.